Product Information

GALANTAMINE ER 16 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.8442 per EA under NDC 65862074530. Its NADAC has been published 495 times since Mar 1, 2017.

FDA first approved this application on Aug 5, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Galantamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GALANTAMINE ER 16 MG CAPSULE

Galantamine
$0.8442per EA
High Outlier

Strength

16 mg/1

NDC

65862074530

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GALANTAMINE HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204895

FDA Approved

8/5/2016

TE Code

AB

On Market Since

8/5/2016

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for GALANTAMINE ER 16 MG CAPSULE has been published 495 times since Mar 1, 2017, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8442 per EA
All-time high$2.0180 (Mar 15, 2017)
All-time low$0.8369 (Jan 22, 2025)
52-week high$0.9913
52-week low$0.8442
Median price$1.3137
Average price$1.3129
Largest weekly change+74.3% (Sep 22, 2021)
Weeks tracked495
Tracking sinceMar 1, 2017

Price History

1W

-10.3%

1M

-10.3%

3M

-10.8%

6M

-7.4%

1Y

-14.1%

3Y

-14.2%

5Y

-13.1%

All

-58.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Galantamine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of GALANTAMINE ER 16 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE ER 16 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.8442 per EA (NDC 65862074530), effective Aug 19, 2026.

How has the price of GALANTAMINE ER 16 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GALANTAMINE ER 16 MG CAPSULE has declined 58.2%. It has been tracked across 495 weekly CMS publications since Mar 1, 2017.

What are the highest and lowest recorded NADAC prices for GALANTAMINE ER 16 MG CAPSULE?

Since Mar 1, 2017, the NADAC for GALANTAMINE ER 16 MG CAPSULE has ranged from a low of $0.8369 (Jan 22, 2025) to a high of $2.0180 (Mar 15, 2017), with a median of $1.3137 per EA.

Are there cheaper alternatives to GALANTAMINE ER 16 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of GALANTAMINE ER 16 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GALANTAMINE ER 16 MG CAPSULE?

GALANTAMINE ER 16 MG CAPSULE (NDC 65862074530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.